Please assess the completion status of the following clinical trial:

Trial Title: LXRs, Cholesterol Metabolism and Uterine Dystocia

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing C-section for a dystocia: 2 to 3 hours of stagnation in labor progress are observed (ie no increasing dilation, and uterine contractions less that 3-5 per 10 minutes) in spite of measures taken to overcome dystocia (oxytocin injection and artificial breaking of waters)~* the child is alive~* the child does not have apriori known malformations that could interfere with a vaginal birth~* foetus in cephalic position~* full term pregnancy (\>= 37 weeks of amenorrhea)~* single birth~* patient has signed consent~* patient is affiliated with a social security system~Exclusion Criteria:~* vaginal birth~* programmed C-section~* C-section is chosen because the fetus has a cardia rhythm problem, and there is no stagnation in the labor process~* multiple pregnancy~* the child is in a breech position~* premature birth (\<37 weeks amenorrhea)~* in utero fetal death~* fetal malformation known before birth that could interfere with a vaginal birth~* non french-speaking patient (impossible to correctly inform the patient)~* patient under guardianship

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: None): Control group: these patients have mechanical dystocia; cholesterol metabolism factors are a priori not involved.
- Group 2 (Type: None): These patients have uterine dystocia

Based on this trial design, predict the completion outcome and termination type (if applicable).